The principal finding of this study is that women with medication-refractory depression display increased expression of genes from diverse biological pathways, including the immune genes IL10 and IL6, the oxytocin receptor OXTR, the growth factor APP, and the metabolite receptors P2RY1, P2RX7, and TRPV1. This evidence concerns the gene IL6 and depressive symptom measurement.